You are here

Pharmaceutical Approval Update January 2010

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Topics include ecallantide (Kalbitor) for hereditary angioedema; a capsaicin 8% patch (Qutenza) for pain management; and romidepsin (Istodax) for patients with cutaneous T-cell lymphoma.